Saturn V Capital Management LP

Position in PCVX — Vaxcyte, Inc.

CIK 1964437 AUSTIN, TX

Position in PCVX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$49,579,890

+$1,666,336 QoQ

Shares Held

852,914

+3.4% QoQ

Ownership

0.573%

of shares outstanding

% of Portfolio

7.11%

of 13F equity value

Holder Rank

#32

of 330 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Saturn V Capital Management LP holds $614,415,149 across 22 Biotechnology names. PCVX ranks #3 (8.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALMS	Alumis Inc.	2,915,443	$82,040,566
2	ABVX	Abivax S.A.	518,865	$69,143,949
3	PCVX	Vaxcyte, Inc. This page	852,914	$49,579,890
4	IMMX	Immix Biopharma, Inc.	4,658,429	$48,028,402
5	PHVS	Pharvaris N.V.	1,314,122	$45,442,338
6	JAZZ	Jazz Pharmaceuticals plc	160,938	$38,781,229
7	CELC	Celcuity Inc.	370,318	$38,742,669
8	IRON	Disc Medicine, Inc.	524,730	$38,378,752

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$49,579,890	852,914	+3.4%	Shares	Sole	2026-08-14
2026-03-31	$47,913,554	824,532	+3.2%	Shares	Sole	2026-05-15
2025-12-31	$36,863,091	798,940	+1.3%	Shares	Sole	2026-02-17
2025-09-30	$28,399,644	788,441	+44.9%	Shares	Sole	2025-11-14
2025-06-30	$17,692,624	544,221	+134.3%	Shares	Sole	2025-08-13
2025-03-31	$8,771,459	232,295	+13.7%	Shares	Sole	2025-05-15
2024-12-31	$16,722,770	204,285	-0.3%	Shares	Sole	2025-02-14
2024-09-30	$23,423,864	204,987	-5.0%	Shares	Sole	2024-11-14
2024-06-30	$16,285,996	215,680	+16.5%	Shares	Sole	2024-08-14
2024-03-31	$12,649,304	185,175	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.